SMS Pharmaceuticals Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 1,494.26 million compared to INR 609.19 million a year ago. Revenue was INR 1,506.82 million compared to INR 613.45 million a year ago. Net income was INR 62.18 million compared to INR 61.74 million a year ago. Basic earnings per share from continuing operations was INR 0.73 compared to INR 0.73 a year ago.
For the full year, sales was INR 5,220.51 million compared to INR 5,198.74 million a year ago. Revenue was INR 5,269.37 million compared to INR 5,250.72 million a year ago. Net loss was INR 70.59 million compared to net income of INR 622.2 million a year ago. Basic loss per share from continuing operations was INR 0.83 compared to basic earnings per share from continuing operations of INR 7.35 a year ago.